ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,513Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 917

$603K Total Retail Price of All Prescriptions

Rank: 73 out of 917

784 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 784 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 784 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,953 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
WARFARIN SODIUM 634 575 1 10
LISINOPRIL 529 434 2 1
LEVOTHYROXINE SODIUM 415 367 3 3
SIMVASTATIN 375 305 4 2
AMLODIPINE BESYLATE 346 316 5 5
ATENOLOL 343 309 6 12
HYDROCODONE-ACETAMINOPHEN 316 235 S3 7 6
OMEPRAZOLE 314 239 8 4
METFORMIN HCL 288 241 9 8
HYDROCHLOROTHIAZIDE 240 214 10 9
ATORVASTATIN CALCIUM 236 200 11 14
PRAVASTATIN SODIUM 225 182 12 20
FUROSEMIDE 221 191 13 7
LOSARTAN POTASSIUM 198 164 14 13
GLIMEPIRIDE 180 146 15 54
CITALOPRAM HBR 177 120 16 15
LOVASTATIN 177 169 16 19
ZOLPIDEM TARTRATE 158 104 18 21
GABAPENTIN 154 98 19 17
OXYCODONE HCL 153 34 S2 20 27
METOPROLOL TARTRATE 138 113 21 11
TRAZODONE HCL 126 79 22 22
FLUTICASONE PROPIONATE 126 98 22 26
POTASSIUM CHLORIDE 115 90 24 16
TAMSULOSIN HCL 110 96 25 25
MORPHINE SULFATE ER 109 53 S2 26 48
TRAMADOL HCL 109 103 26 28
ALLOPURINOL 100 90 28 31
SERTRALINE HCL 100 67 28 24
ALENDRONATE SODIUM 99 77 30 23
CYCLOBENZAPRINE HCL 91 34 R 31 65
ADVAIR DISKUS 89 82 32 47
METOPROLOL SUCCINATE 86 80 33 18
BENAZEPRIL HCL 83 73 34 80
DONEPEZIL HCL 81 77 35 32
FLUOXETINE HCL 79 53 36 38
OXYCONTIN 78 40 S2 37 100
PREDNISONE 74 56 38 34
TRIAMCINOLONE ACETONIDE 71 54 39 96
FENOFIBRATE 67 53 40 73
PROAIR HFA 66 52 41 35
OXYCODONE-ACETAMINOPHEN 62 28 S2 42 46
CRESTOR 61 61 43 30
PANTOPRAZOLE SODIUM 59 57 44 44
METHADONE HCL 57 13 S2 45 59
LANTUS 57 55 45 37
DIGOXIN 55 55 47 41
AMITRIPTYLINE HCL 53 23 R 48 67
MORPHINE SULFATE 50 0 S2 49 173
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.